SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $43.42 | 52-week high | $48.76 |
Prev. close | $43.25 | 52-week low | $38.88 |
Day low | $43.07 | Volume | 58,300 |
Day high | $43.97 | Avg. volume | 43,590 |
50-day MA | $45.94 | Dividend yield | 1.62% |
200-day MA | $42.91 |
XPH Stock Price Chart Interactive Chart >
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Pharmaceuticals Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 155.58M |
Net Asset Value (NAV) | $43.21 |
Options? | Yes |
Total Holdings | 46 |
XPH Top Holdings
Symbol | Company | % of Total |
CORT | CORCEPT THERAPEUTICS INC | 5.18% |
BMY | BRISTOL MYERS SQUIBB CO | 4.42% |
JAZZ | JAZZ PHARMACEUTICALS PLC | 4.36% |
ITCI | INTRA CELLULAR THERAPIES INC | 4.31% |
VTRS | VIATRIS INC | 4.01% |
AXSM | AXSOME THERAPEUTICS INC | 3.7% |
EWTX | EDGEWISE THERAPEUTICS INC | 3.59% |
PRGO | PERRIGO CO PLC | 3.58% |
TARS | TARSUS PHARMACEUTICALS INC | 3.5% |
PFE | PFIZER INC | 3.4% |
XPH Price Returns
1-mo | -6.76% |
3-mo | -1.09% |
6-mo | 8.94% |
1-year | 7.16% |
3-year | -3.33% |
5-year | -1.26% |
YTD | 5.62% |
2023 | 2.97% |
2022 | -9.83% |
2021 | -10.54% |
2020 | 14.68% |
2019 | 25.61% |
XPH Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |